Therapeutic Management of Hypothyroidism With Concurrent Babesiosis in a Non-Descript Dog

    Bendangla Changkija, Inzamamul Haque Laskar, Dolly Thakur, Harshit Singh, Ditul Barman, Deepa Lahkar, Utpal Barman, Mousumi Hazorika, Arabinda Phukan
    TLDR The dog improved significantly after treatment and needs lifelong thyroid medication.
    A 4-year-old non-descript dog with symptoms including fever, alopecia, and lethargy was diagnosed with primary hypothyroidism and concurrent Babesia gibsoni infection. The dog was treated with Diminazine aceturate, metronidazole, doxycycline, clindamycin, and supportive drugs for the babesia infection, and Thyroxine sodium for hypothyroidism. Additional support included iron supplements, antiemetics, acid blockers, essential fatty acids, Vitamin A, and B-complexes for about one month. By day 30 post-treatment, the dog showed significant clinical improvement, with negative blood smears for babesia and increased T4 levels. Lifelong Thyroxine sodium treatment was recommended with regular evaluations every 3 months. The case highlights successful management of both conditions.
    Discuss this study in the Community →